Surgery Partners Inc (NASDAQ:SGRY) Expected to Post Earnings of -$0.20 Per Share
Equities analysts expect Surgery Partners Inc (NASDAQ:SGRY) to report earnings of ($0.20) per share for the current quarter, according to Zacks. Three analysts have made estimates for Surgery Partners’ earnings. The lowest EPS estimate is ($0.29) and the highest is ($0.03). Surgery Partners reported earnings of ($0.19) per share in the same quarter last year, which indicates a negative year-over-year growth rate of 5.3%. The firm is scheduled to announce its next quarterly earnings results on Wednesday, November 6th.
On average, analysts expect that Surgery Partners will report full year earnings of ($0.75) per share for the current year, with EPS estimates ranging from ($1.02) to ($0.44). For the next year, analysts expect that the business will post earnings of ($0.26) per share, with EPS estimates ranging from ($0.78) to $0.25. Zacks’ EPS averages are an average based on a survey of sell-side analysts that that provide coverage for Surgery Partners.
Surgery Partners (NASDAQ:SGRY) last released its quarterly earnings data on Wednesday, August 7th. The company reported ($0.35) EPS for the quarter, missing analysts’ consensus estimates of ($0.22) by ($0.13). The business had revenue of $445.40 million during the quarter, compared to analyst estimates of $450.89 million. Surgery Partners had a negative net margin of 11.61% and a negative return on equity of 4.65%. The company’s revenue was up 2.0% on a year-over-year basis. During the same quarter in the prior year, the company posted ($0.57) earnings per share.
Shares of Surgery Partners stock traded up $0.81 during trading hours on Friday, hitting $8.50. The company’s stock had a trading volume of 47,556 shares, compared to its average volume of 327,969. Surgery Partners has a twelve month low of $5.38 and a twelve month high of $17.25. The firm has a fifty day moving average of $6.59 and a 200-day moving average of $9.35. The stock has a market cap of $346.34 million, a price-to-earnings ratio of -3.36 and a beta of 2.32. The company has a debt-to-equity ratio of 2.29, a quick ratio of 1.32 and a current ratio of 1.43.
In related news, COO Jason Eric Evans acquired 25,000 shares of the stock in a transaction that occurred on Tuesday, August 20th. The stock was purchased at an average price of $5.95 per share, with a total value of $148,750.00. Following the transaction, the chief operating officer now owns 111,655 shares of the company’s stock, valued at approximately $664,347.25. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 2.30% of the company’s stock.
Several hedge funds and other institutional investors have recently modified their holdings of the company. Royal Bank of Canada raised its holdings in shares of Surgery Partners by 64.3% in the 2nd quarter. Royal Bank of Canada now owns 5,750 shares of the company’s stock valued at $47,000 after buying an additional 2,250 shares during the period. Quantamental Technologies LLC bought a new stake in shares of Surgery Partners during the 1st quarter valued at about $50,000. Tower Research Capital LLC TRC acquired a new stake in Surgery Partners during the second quarter worth about $57,000. Menta Capital LLC bought a new position in Surgery Partners in the second quarter worth about $107,000. Finally, Jefferies Group LLC lifted its holdings in Surgery Partners by 22.4% in the second quarter. Jefferies Group LLC now owns 19,071 shares of the company’s stock worth $155,000 after acquiring an additional 3,490 shares during the last quarter. 96.32% of the stock is owned by institutional investors and hedge funds.
About Surgery Partners
Surgery Partners, Inc, through its subsidiaries, owns and operates a network of surgical facilities and related services in the United States. The company operates through three segments: Surgical Facility Services, Ancillary Services, and Optical Services. Its surgical facilities comprise ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including gastroenterology, general surgery, ophthalmology, orthopedics, and pain management.
Featured Story: How Investors Use a Balance Sheet
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Surgery Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners and related companies with MarketBeat.com's FREE daily email newsletter.